McKesson 2014 Annual Report Download - page 8

McKESSON CORPORATION
5
Institutional Healthcare Providers — Electronic ordering/purchasing and supply chain management systems that help
customers improve financial performance, increase operational efficiencies and deliver better patient care. Solutions include:
• Fulfill-RxSM — Ordering and inventory management system that empowers hospitals to optimize the often complicated and
disjointed processes related to unit-based cabinet replenishment and inventory management.
• Asset Management — Award-winning inventory optimization and purchasing management program that helps institutional
providers lower costs while ensuring product availability.
• SKY Packaging — Blister-format packaging containing the most widely prescribed dosages and strengths in generic oral-
solid medications. SKY Packaging enables acute care, long-term care and institutional pharmacies to provide cost-effective,
uniform packaging.
• McKesson Plasma and BioLogics — A full portfolio of plasma-derivatives and biologic products.
• McKesson OneStop Generics® — Generic pharmaceutical purchasing program that helps pharmacies maximize their cost
savings with a broad selection of generic drugs, low pricing and one-stop shopping.
• McKesson 340B Solution Suite and Macro Helix® — Solutions that help providers manage, track and report on medication
replenishment associated with the federal 340B Drug Pricing Program.
Independent Retail Pharmacies — Solutions for managed care contracting, branding and advertising, merchandising,
purchasing, operational efficiency and automation that help independent pharmacists focus on patient care while improving
profitability. Solutions include:
• Health Mart® — Health Mart® is a national network of more than 3,000 independently-owned pharmacies and is one of the
industry’s most comprehensive pharmacy franchise programs. Health Mart® provides franchisees support for managed care
contracting, branding and local marketing solutions, the Health Mart private label line of products, merchandising solutions
and programs for enhanced patient support.
• AccessHealth® — Comprehensive managed care and reconciliation assistance services that help independent pharmacies
save time, access competitive reimbursement rates and improve cash flow.
• McKesson Reimbursement AdvantageSM (“MRA”) — MRA is one of the industry’s most comprehensive reimbursement
optimization packages, comprising financial services (automated claim resubmission), analytic services and customer care.
• McKesson OneStop Generics® — described above.
• EnterpriseRx® — described above.
• Sunmark® — Complete line of more than 700 products that provide retail independent pharmacies with value-priced
alternatives to national brands.
• FrontEdge™ — Strategic planning, merchandising and price maintenance program that helps independent pharmacies
maximize store profitability.
• McKesson Sponsored Clinical Services (SCS) Network — Access to patient-support services that allow pharmacists to earn
service fees and develop stronger patient relationships.
McKesson Specialty Health: This business provides solutions for oncology and other specialty practices operating in
communities across the country, as well as for pharmaceutical and biotech suppliers who manufacture specialty drugs and vaccines,
payers and hospitals. Through expertise in specialty drug distribution, commercialization, revenue cycle and practice management
and reimbursement support, McKesson Specialty Health seeks to empower the community patient care delivery system and
facilitates collaboration among community healthcare providers, drug manufacturers and payers. We provide direct-to-physician
specialty distribution services, ensuring supply chain safety and delivery of specialty drugs in manufacturer recommended
conditions. Third party logistics, or 3PL, are offered primarily for vaccine distribution, including our exclusive distributor
relationship in the Centers for Disease Control and Prevention’s (CDC) Vaccines for Children program. When classifying a
pharmaceutical product or service as “specialty,” we consider the following factors: high cost; diseases requiring complex treatment
regimens such as cancer and rheumatoid arthritis; special handling, storage and delivery requirements; and, in some cases, exclusive
distribution arrangements. This business also provides practice management and other consulting services to healthcare providers,
pharmaceutical manufacturers and third party payers supporting the clinical research and distribution of specialty pharmaceutical
products and services. Our use of the term “specialty” to define a portion of our distribution business may not be comparable to
that used by other industry participants, including our competitors.